Medication Guide App

Label Changes for:

Cyanokit (hydroxocobalamin) intravenous use

October 2010

Changes have been made to the PRECAUTIONS sections of the safety label.

Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER) – October 2010

 

USE IN SPECIFIC POPULATIONS

Pregnancy
  • Based on animal studies, may cause fetal harm; however, treatment of maternal/fetal cyanide poisoning may be lifesaving.
Nursing mothers
  • Because of the unknown potential for adverse reactions in nursing infants, discontinue nursing after Cyanokit treatment
Hide
(web2)